For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $72.10 in the prior trading day, Vaxcyte Inc (NASDAQ: PCVX) closed at $70.24, down -2.58%. In other words, the price has decreased by -$2.58 from its previous closing price. On the day, 1.39 million shares were traded.
Ratios:
Our goal is to gain a better understanding of PCVX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.75 and its Current Ratio is at 12.75. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 20, 2024, initiated with a Buy rating and assigned the stock a target price of $135.
On December 07, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $69.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when Wassil Jim sold 8,000 shares for $73.27 per share. The transaction valued at 586,165 led to the insider holds 154,931 shares of the business.
Wassil Jim bought 8,000 shares of PCVX for $585,360 on Mar 03 ’25. On Feb 18 ’25, another insider, GUGGENHIME ANDREW, who serves as the PRESIDENT AND CFO of the company, sold 8,000 shares for $83.85 each. As a result, the insider received 670,823 and left with 109,491 shares of the company.
Stock Price History:
Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $58.10. The 50-Day Moving Average of the stock is -16.63%, while the 200-Day Moving Average is calculated to be -21.20%.
Shares Statistics:
A total of 128.76M shares are outstanding, with a floating share count of 124.98M. Insiders hold about 2.93% of the company’s shares, while institutions hold 107.88% stake in the company.
Earnings Estimates
Current recommendations for the stock of the company come from 2.0 analysts. The consensus estimate for the next quarter is -$0.97, with high estimates of -$0.86 and low estimates of -$1.08.
Analysts are recommending an EPS of between -$3.48 and -$4.88 for the fiscal current year, implying an average EPS of -$4.3. EPS for the following year is -$4.9, with 6.0 analysts recommending between -$4.14 and -$5.8.
